Uddhavesh Sonavane

Dr. Uddhavesh Sonavane


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2009 in Inorganic Chemistry
Verified
Journal Article
Closed access
ABArchika Barve
Archika Barve
AKAvinash Kumbhar
Avinash Kumbhar
MBMenakshi Bhat
Menakshi Bhat
BJBimba Joshi
Bimba Joshi
RBRay Butcher
Ray Butcher
RJRajendra Joshi
Rajendra Joshi

1 March 2006 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
SGSmita Ghosh
Smita Ghosh
ABArchika C. Barve
Archika C. Barve
AKAnupa Kumbhar
Anupa Kumbhar
AKAvinash S. Kumbhar
Avinash S. Kumbhar
VPVedavati G. Puranik
Vedavati G. Puranik
RJRajendra Joshi
Rajendra Joshi

23 February 2009 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MDMegha S. Deshpande
Megha S. Deshpande
AKAnupa A. Kumbhar
Anupa A. Kumbhar
AKAvinash S. Kumbhar
Avinash S. Kumbhar
MKManoj Kumbhakar
Manoj Kumbhakar
HPHaridas Pal
Haridas Pal
RJRajendra R. Joshi
Rajendra R. Joshi

1 March 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NVNilima A. Vyas
Nilima A. Vyas
SBSatish S. Bhat
Satish S. Bhat
AKAvinash S. Kumbhar
Avinash S. Kumbhar
USUddhavesh Sonavane
Uddhavesh Sonavane
VJVinod Jani
Vinod Jani
BJBimba Joshi
Bimba Joshi

3 December 2010 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
VKVitthal A. Kawade
Vitthal A. Kawade
AKAnupa A. Kumbhar
Anupa A. Kumbhar
AKAvinash S. Kumbhar
Avinash S. Kumbhar
CNChristian Näther
Christian Näther
Andrea ErxlebenAndrea Erxleben
Andrea Erxleben
RJRajendra R. Joshi
Rajendra R. Joshi
Complexes of the type [Co(pic)2(NN)], where pic = picolinate, NN = dipyrido[3,2-d:2′,3′-f]quinoxaline (dpq) (4) and 4b,5,7,7a-tetrahydro-4b,7a-epiminomethanoimino-6H-imidazo[4,5-f][1,10]-phenanthroline-6,13-dione (bipyridyl-glycoluril) (bpg) (6) have been synthesized and characterized by elemental analysis, IR, UV-vis, NMR and ESI–MS spectroscopy and thermogravimetic analysis (TGA). Their physicochemical properties are compared with previously synthesized complexes, where NN = (H2O)2 (1), 2,2′-bipyridine (bpy) (2), 1,10-phenanthroline (phen) (3) and dipyrido[3,2-a:2′,3′-c]phenazine (dppz) (5). The crystal structures of the complexes 4–6 were solved by single-crystal X-ray diffraction. The complexes 4 and 5 crystallize from a mixture of chloroform and methanol in monoclinic and orthorhombic crystal systems, respectively, whereas complex 6 crystallizes from dimethyl sulfoxide (DMSO) in a tetragonal crystal system. The coordination sphere consists of two oxygen atoms and two nitrogen atoms from the two picolinates and two nitrogen atoms from the dpq, dppz or bpg ligand, respectively. Co(II)/Co(III) oxidation potentials have been determined by cyclic voltammetry. The DNA binding of complexes 1–5 has been investigated using thermal melting, fluorescence quenching and viscosity measurements, which indicate the partial intercalation of complex 5 with an apparent binding constant (kapp) of 8.3 × 105 M−1. DNA cleavage studies of complexes 1–5 have been investigated using gel electrophoresis in the presence of H2O2 as an oxidizing agent and also by photoirradiation at 365 nm. The mechanistic investigations suggest that singlet oxygen ( 1O2 ) is the major species involved in the DNA cleavage by these complexes. The structures of complexes 2–6 were optimized with density functional theory (DFT) method (B3LYP/6-31G(d,p)). The low vertical ionization potential values indicate photoredox pathways for the DNA cleavage activity by complexes 4 and 5, which is corroborated by DNA cleavage experiments.

17 July 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MUMallikarjunachari V. N. Uppuladinne
Mallikarjunachari V. N. Uppuladinne
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
The efforts towards developing a potential drug against the current global pandemic, COVID-19, have increased in the past few months. Drug development strategies to target the RNA dependent RNA polymerase (RdRP) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are being tried worldwide. The gene encoding this protein, is known to be conserved amongst positive strand RNA viruses. This enables an avenue to repurpose the drugs designed against earlier reported inhibitors of RdRP. One such strong inhibitor is remdesivir which has been used against EBOLA infections. The binding of remdesivir to RdRP of SARS-CoV-2 has been studied using the classical molecular dynamics and ensemble docking approach. A comparative study of the simulations of RdRP in the apo and remdesivir-bound form revealed blocking of the template entry site in the presence of remdesivir. The conformation changes leading to this event were captured through principal component analysis. The conformational and thermodynamic parameters supported the experimental information available on the involvement of crucial arginine, serine and aspartate residues belonging to the conserved motifs in RdRP functioning. The catalytic site comprising of SER 759, ASP 760, and ASP 761 (SDD) was observed to form strong contacts with remdesivir. The significantly strong interactions of these residues with remdesivir may infer the latter's binding similar to the normal nucleotides thereby remaining unidentified by the exonuclease activity of RdRP. The ensemble docking of remdesivir too, comprehended the involvement of similar residues in interaction with the inhibitor. This information on crucial interactions between conserved residues of RdRP with remdesivir through in silico approaches may be useful in designing inhibitors.